March 25, 2026 - ET (Eastern Time, GMT-05:00)
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
- Building influence without authority 
- Emotional intelligence in high-stakes financial environments 
- Personal brand development 
- Learning through change and uncertainty 
- Cross-cultural communication in global life sciences operations 
- Networking for career advancement 
- Mallory Morales - Chief Accounting Officer, Treasurer, Immuneering Corporation
- Tara Ruggeri - Head of Global Transaction Support, Sanofi
- Thomas Cunningham - Assistant Controller, Merck
- Most Favored Nation pricing models: financial implications and response strategies 
- Tariffs and trade barriers: quantifying the P&L impact from clinical supply, inventory, and COGS 
- Big Beautiful Bill impact 
- California Climate Disclosure Laws 
- CSRD 
- Staying up to date on the changing regulatory landscape 
- Preparation for assurance 
- Sarah Stiff - ESG Controller, Legend Biotech
- Nathan Knies - Director, Sustainability Controller, Eli Lilly & Co
The Speed Roundtables session offers a dynamic, structured networking opportunity designed to facilitate meaningful connections between life sciences companies and solution providers in a time-efficient format. This high-energy session transforms traditional networking into a series of focused, productive conversations that deliver maximum value for both pharmaceutical/biotech professionals and sponsoring organizations.
Example themes include:
- Financial Planning & Analysis Transformation 
- Revenue Recognition Automation 
- Clinical Trial Financial Management 
- Supply Chain Financial Visibility 
- Tax Strategy for Global Operations 
- Regulatory Compliance Technology 
- Technical deep dives 
- Industry-specific applications 
- Emerging trends and future focus 
- Evolving Audit Committee Priorities in Life Sciences 
- Financial Reporting Quality and Transparency 
- Risk Oversight Beyond Traditional Financial Concerns 
- Audit Committee and External Auditor Dynamics 
- Internal Audit Function Effectiveness 
- Board and Committee Effectiveness 
- Rita Karachun - Former Senior Vice President Finance, Global Controller, Merck
Following an immersive 2.5 days of knowledge infusion, you now have a unique opportunity to delve deeper into your acquired insights. Engage in interactive working group discussions, where you will have the opportunity to dissect your recent learnings and foster peer interactions that not only cultivate new relationships but also reinvigorate your professional objectives as you return to your workplace.
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
